Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C5H7NO3.C4H11NO |
| Molecular Weight | 218.2502 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCO.OC(=O)[C@@H]1CCC(=O)N1
InChI
InChIKey=DAEHWWVKPWBXGD-DFWYDOINSA-N
InChI=1S/C5H7NO3.C4H11NO/c7-4-2-1-3(6-4)5(8)9;1-5(2)3-4-6/h3H,1-2H2,(H,6,7)(H,8,9);6H,3-4H2,1-2H3/t3-;/m0./s1
| Molecular Formula | C5H7NO3 |
| Molecular Weight | 129.114 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | C4H11NO |
| Molecular Weight | 89.1362 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DEANOL is an inactive component of CERAVE® hydrocortisone anti-itch cream, which is used for temporarily relieve itching associated with minor skin irritations, inflammation, and rashes due to eczema, soaps, detergents, cosmetics, seborrheic dermatitis, psoriasis. DEANOL is also used as a food additive.
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
0.1 % single, topical Highest studied dose Dose: 0.1 % Route: topical Route: single Dose: 0.1 % Sources: Page: p.10 |
healthy Health Status: healthy Sources: Page: p.10 |
|
6000 mg 1 times / day multiple, oral Highest studied dose Dose: 6000 mg, 1 times / day Route: oral Route: multiple Dose: 6000 mg, 1 times / day Sources: Page: p.188 |
unhealthy Health Status: unhealthy Condition: Involuntary movement disorders Sources: Page: p.188 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Improved method for the quality assurance of [C-11]choline. | 2002 Apr |
|
| Studies of the side chain cleavage of deramciclane in rats with radiolabelled compounds. | 2002 Mar |
|
| [18F]fluoromethyl triflate, a novel and reactive [18F]fluoromethylating agent: preparation and application to the on-column preparation of [18F]fluorocholine. | 2002 Sep |
|
| [Fluorescent-labeled lipophilic analogues of serotonin, dopamine, and acetylcholine: synthesis, mass spectrometry, and biological activity]. | 2004 Sep-Oct |
|
| The role of dimethylaminoethanol in cosmetic dermatology. | 2005 |
|
| The evolution of senescence and post-reproductive lifespan in guppies (Poecilia reticulata). | 2006 Jan |
|
| Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties of novel indeno[2,1-c]quinolin-7-one and indeno[1,2-c]isoquinolin-5,11-dione derivatives. | 2008 Jun 26 |
|
| In vivo skin effects of a dimethylaminoethanol (DMAE) based formulation. | 2009 Dec |
|
| Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies. | 2009 Dec |
|
| The pentameric vertex proteins are necessary for the icosahedral carboxysome shell to function as a CO2 leakage barrier. | 2009 Oct 21 |
|
| Application of high performance liquid chromatography coupled to on-line solid-phase extraction-nuclear magnetic resonance spectroscopy for the analysis of degradation products of V-class nerve agents and nitrogen mustard. | 2010 Apr 23 |
|
| First efficient synthesis of fluorinated glycidic esters from ketones. | 2010 Feb 19 |
|
| Structural characterization and stability of dimethylaminoethanol and dimethylaminoethanol bitartrate for possible use in cosmetic firming. | 2010 Jul-Aug |
|
| In vitro cytotoxicity of benzopyranone derivatives with basic side chain against human lung cell lines. | 2010 Nov |
|
| Novel pathway to synthesize unsymmetrical 2,3,9,10,16,17,23-heptakis(alkoxyl)-24-mono(dimethylaminoalkoxyl)phthalocyanines. | 2010 Oct 4 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:00:07 GMT 2023
by
admin
on
Sat Dec 16 10:00:07 GMT 2023
|
| Record UNII |
V68I8147P0
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID60946233
Created by
admin on Sat Dec 16 10:00:07 GMT 2023 , Edited by admin on Sat Dec 16 10:00:07 GMT 2023
|
PRIMARY | |||
|
23513-72-6
Created by
admin on Sat Dec 16 10:00:07 GMT 2023 , Edited by admin on Sat Dec 16 10:00:07 GMT 2023
|
PRIMARY | |||
|
SUB13537MIG
Created by
admin on Sat Dec 16 10:00:07 GMT 2023 , Edited by admin on Sat Dec 16 10:00:07 GMT 2023
|
PRIMARY | |||
|
71777631
Created by
admin on Sat Dec 16 10:00:07 GMT 2023 , Edited by admin on Sat Dec 16 10:00:07 GMT 2023
|
PRIMARY | |||
|
100000079518
Created by
admin on Sat Dec 16 10:00:07 GMT 2023 , Edited by admin on Sat Dec 16 10:00:07 GMT 2023
|
PRIMARY | |||
|
236195
Created by
admin on Sat Dec 16 10:00:07 GMT 2023 , Edited by admin on Sat Dec 16 10:00:07 GMT 2023
|
PRIMARY | RxNorm | ||
|
245-706-1
Created by
admin on Sat Dec 16 10:00:07 GMT 2023 , Edited by admin on Sat Dec 16 10:00:07 GMT 2023
|
PRIMARY | |||
|
V68I8147P0
Created by
admin on Sat Dec 16 10:00:07 GMT 2023 , Edited by admin on Sat Dec 16 10:00:07 GMT 2023
|
PRIMARY | |||
|
SUB29994
Created by
admin on Sat Dec 16 10:00:07 GMT 2023 , Edited by admin on Sat Dec 16 10:00:07 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |